Myelofibrosis With High Molecular Risk Mutations
3 clinical trials · Condition
◉ Watch Myelofibrosis With High Molecular Risk Mutations
| Record | Firm | Date |
|---|---|---|
| Flonoltinib Maleate Oral Regimens in Patients With Myelofibrosis (NCT07750574) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-11-01 |
| MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) (NCT07362225) | MPN Research Foundation | 2025-09-26 |
| Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations. (NCT02598297) | Novartis Pharmaceuticals | 2016-02-03 |
Track Myelofibrosis With High Molecular Risk Mutations automatically
Every clearance here is in the API, with alerts when new ones post.